Professional Documents
Culture Documents
GENERAL REPORTS
Rezumat Summary
Limfangita carcinomatoasã este o entitate rarã, repre- Carcinomatous lymphangitis is a rare entity,
zentând mai puþin de 5% din totalul metastazelor cutanate. representing less than 5% of cutaneous metastasis.
Prezentãm cazul unei paciente în vârstã de 67 ani, cu We present a patient aged 67 years with ovarian
carcinom ovarian operat ºi polichimiotratat, care a dezvoltat carcinoma operated and multi chemo treated, who
la 6 ani de la debutul bolii o leziune cutanatã laterotoracicã developed within six years of disease skin lesion right
dreaptã, cu suspiciunea de metastazã cutanatã. lateral cutaneous metastasis suspicion.
Valoarea markerului CA-125 în creºtere ºi biopsia cu The value of rising CA-125 marker and histopathology
examen histopatologic au stabilit diagnosticul de limfangitã biopsy were diagnosed the cutaneous carcinomatous
carcinomatoasã cutanatã cu origine ovarianã primitivã. lymphangitis with primitive ovarian origin.
Tratamentul a constat în hipertermie localã ºi Treatment consisted of local hyperthermia and
chimioterapie sistemicã, cu rezultat clinic ºi biologic systemic chemotherapy with biological and favorable
favorabil, însã prognosticul se menþine rezervat. clinical outcome, but prognosis remains reserved.
Cuvinte cheie: limfangita carcinomatoasã cutanatã, Keywords: cutaneous carcinoma lymphangitis,
origine ovarianã. ovarian origin.
Intrat în redacþie: 12.01.2015 Received: 12.01.2015
Acceptat: 21.02.2015 Accepted: 21.02.2015
Introducere Introduction
Afectarea metastaticã a pielii este întâlnitã Damage metastatic skin cancer is relatively
relativ rar în cancer, incidenþa metastazelor rare meeting, incidence of skin metastases in
cutanate la pacienþii cu cancer metastatic fiind de patients with metastatic cancer is approximately
aproximativ 5%. Limfangita carcinomatoasã, 5%. Carcinomatous lymphangitis, also called
31
DermatoVenerol. (Buc.), 60: 31-37
32
DermatoVenerol. (Buc.), 60: 31-37
Ciclofosfamidã. Evaluarea imagisticã ulterioarã a formations indicate the presence on right lateral
evidenþiat boalã staþionarã ºi s-a decis chest wall. The admission for the performance
continuarea a încã 2 cicluri de chimioterapie. În cycle 7, there is enlargement of the formation of
paralel cu încheierea ciclului 6, se constatã skin and dermatological examination is
prezenþa unei formaþiuni cutanate la nivelul requested.
peretelui toracic lateral drept. La internarea Clinical examination revealed a general
pentru efectuarea ciclului 7, se constatã creºterea performance index = 2 and fever (38.2 degrees
în dimensiuni a formaþiunii cutanate ºi se solicitã Celsius). Dermatologic examination revealed an
consult dermatologic. infiltrated placard located abdominal sideway
Examenul clinic general a evidenþiat un right-violet eritemato of 8/6 cm, endured
indice de performanþã = 2 ºi febrã (38,2 grade irregular edges imprecisely defined (Fig. 1).
Celsius). Examenul dermatologic a pus în Inside the lesion was palpable cords firm,
evidenþã un placard infiltrat, localizat latero- sinuous. The lesion was accompanied by pain
abdominal drept, eritemato-violaceu, de 8/6 cm,
and local heat. Following clinical history and
indurat, neregulat, cu margini imprecis deli-
physical examination have established the
mitate (fig. 1). În interiorul leziunii erau palpabile
clinical diagnosis of cutaneous metastasis
cordoane ferme, sinuoase. Leziunea era însoþitã
suspected ovarian serous papillary carcinoma.
de durere ºi cãldurã localã. În urma anamnezei ºi
Differential diagnosis has imposed: erysipelas,
a examenului clinic, am stabilit diagnosticul
clinic suspiciune de metastazã cutanatã de cellulitis, migratory superficial thrombophlebitis
carcinom papilar seros ovarian. Diagnosticul (Trousseau’s disease), superficial phlebitis
diferenþial s-a impus cu: erizipel, celulitã, sclerosing (Mondor disease), ecchymosis (tab. 1).
tromboflebitã superficialã migratorie (boala Laboratory explorations showed elevated
Trousseau), flebitã sclerozantã superficialã (boala values of CA-125 (368.2 U / mL to 171.8 U / ml-
Mondor), echimozã (tab. 1). value established during previous admission);
Explorãrile paraclinice au evidenþiat valori blood count, kidney and liver samples within
elevate ale CA-125 (368,2 U/ml faþã de 171,8 normal limits. Doppler ultrasound revealed no
U/ml- valoarea stabilitã în cursul internãrii changes in inflammatory or thrombotic vein
precedente); hemoleucogramã, probe renale ºi abdominal side. For the diagnosis of certainty,
hepatice în limite normale. Ecografia Doppler nu local anesthesia with Xiline 1%, to biopsy the
a pus în evidenþã modificãri inflamatorii sau lesion, the sample was sent for histopathological
trombotice ale venelor lateroabdominale. Pentru examination.
33
DermatoVenerol. (Buc.), 60: 31-37
Tabel 1
Table 1
34
DermatoVenerol. (Buc.), 60: 31-37
Fig. 2. Aspectul histopatologic în coloraþie hematoxilinã- Fig. 3. Aspectul histopatologic în coloraþie hematoxilinã-
eoxinã, obiectiv 20X: emboli tumorali intralimfatici, eoxinã, obiectiv 20X: emboli tumorali intralimfatici,
formaþi din carcinom micropapilar formaþi din carcinom micropapilar
Fig. 2. Histopathological appearance in hematoxylin-eoxin Fig. 3. Histopathological appearance in hematoxylin-eoxin
staining, 20X objective: intra lymphatic tumor emboli staining, 20X objective: intra lymphatic tumor emboli
formed from micropapilar carcinoma formed from micropapilar carcinoma
35
DermatoVenerol. (Buc.), 60: 31-37
36
DermatoVenerol. (Buc.), 60: 31-37
Bibliografie/Bibliography
1. Burgdorf WH, Plewig G, Wolff HH et al. Braun-Falco’s Dermatology. 3rd ed. Heidelberg: Springer; 2009: 120-122, 926.
2. Hager ED. Locoregional Hyperthermia. In: Madame Curie Bioscience Database [Internet]. Austin (TX): Landes
Bioscience; 2000-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK6347
3. Marcoval J, Moreno A, Peyrí J. Cutaneous infiltration by cancer. J Am Acad Dermatol 2007;57(October (4)):577–80.
4. Saeed S, Keehn CA, Morgan MB. Cutaneous metastasis: a clinical, pathological and immunohistochemical
appraisal. J Cutan Pathol 2004;31(July (6)): 419–30.
37